Literature DB >> 18174661

Genetic association of low-density lipoprotein receptor-related protein 2 (LRP2) with plasma lipid levels.

Akiko Mii1, Toshiaki Nakajima, Yuko Fujita, Yasuhiko Iino, Kouhei Kamimura, Hideaki Bujo, Yasushi Saito, Mitsuru Emi, Yasuo Katayama.   

Abstract

AIM: Not all genetic factors predisposing phenotypic features of dyslipidemia have been identified. We studied the association between the low density lipoprotein-related protein 2 gene (LRP2) and levels of plasma total cholesterol (T-Cho) and LDL-cholesterol (LDL-C) among 352 adults in Japan.
METHODS: Subjects were obtained from among participants in a cohort study that was carried out with health-check screening in an area of east-central Japan. We selected 352 individuals whose LDL-C levels were higher than 140 mg/dL from the initially screened 22,228 people. We assessed the relation between plasma cholesterol levels and single-nucleotide polymorphisms (SNPs) in the LRP2 gene.
RESULTS: We identified significant correlations between plasma cholesterol levels and two of 19 examined SNPs in LRP2, c.+193826T/C and IVS55 - 147A/G. In particular, the association of c.+193826T/C with the T-Cho level was prominent (p=0.003), showing a co-dominant effect of the minor C-allele on lowering T-Cho and LDL-C levels: for 24 homozygous C-allele carriers, T-Cho=240.7 +/- 24.2 mg/dL and LDL-C=166.1 +/- 21.0 mg/dL); for 130 heterozygous carriers, 248.5 +/- 23.5 mg/dL and 166.6 +/- 19.3 mg/dL; and for 196 homozygous T-allele carriers, 253.9 +/- 23.5 mg/dL and 172.0 +/- 21.0 mg/dL. Linkage disequilibrium (LD) analyses based on 19 selected SNPs showed that c.+193826T/C and IVS55 - 147A/G were in tight LD and that both were located in an LD block covering the genomic sequence from exon 55 to exon 61.
CONCLUSION: We confirm the association between LRP2 and levels of T-Cho and LDL-C in human plasma. The results suggest that genetic variations in LRP2 are important factors affecting lipoprotein phenotypes of patients with hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18174661     DOI: 10.5551/jat.e494

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  7 in total

Review 1.  Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis.

Authors:  Gwang-Woong Go; Arya Mani
Journal:  Yale J Biol Med       Date:  2012-03-29

2.  Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that models myopia and other risk factors for glaucoma.

Authors:  Kerry N Veth; Jason R Willer; Ross F Collery; Matthew P Gray; Gregory B Willer; Daniel S Wagner; Mary C Mullins; Ava J Udvadia; Richard S Smith; Simon W M John; Ronald G Gregg; Brian A Link
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917

3.  A Comprehensive Inter-Tissue Crosstalk Analysis Underlying Progression and Control of Obesity and Diabetes.

Authors:  Pawan Samdani; Meet Singhal; Neeraj Sinha; Parul Tripathi; Sachin Sharma; Kamiya Tikoo; Kanury V S Rao; Dhiraj Kumar
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

4.  Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway.

Authors:  Yang He; Lingling Cao; Li Wang; Lingping Liu; Ying Huang; Xuan Gong
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

5.  Megalin-Mediated Trafficking of Mitochondrial Intracrines: Relevance to Signaling and Metabolism.

Authors:  David Sheikh-Hamad; Michael Holliday; Qingtian Li
Journal:  J Cell Immunol       Date:  2021-11-23

6.  Renal LRP2 expression in man and chicken is estrogen-responsive.

Authors:  Julia A Plieschnig; Eva T Gensberger; Tarek M Bajari; Wolfgang J Schneider; Marcela Hermann
Journal:  Gene       Date:  2012-07-31       Impact factor: 3.688

7.  Common variants of a urate-associated gene LRP2 are not associated with gout susceptibility.

Authors:  Akiyoshi Nakayama; Hirotaka Matsuo; Toru Shimizu; Yuzo Takada; Takahiro Nakamura; Seiko Shimizu; Toshinori Chiba; Masayuki Sakiyama; Mariko Naito; Emi Morita; Kimiyoshi Ichida; Nariyoshi Shinomiya
Journal:  Rheumatol Int       Date:  2013-12-24       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.